# Paper Review — PMID 42459945

**Title:** A framework for assessing algorithmic discrimination risks in training data: a case of pediatric type 1 diabetes
**Authors:** Bilionis I, Berrios RC, de Arriba Muñoz A
**Journal:** JAMIA Open, 2026-Aug · DOI: [10.1093/jamiaopen/ooag125](https://doi.org/10.1093/jamiaopen/ooag125) · [PubMed](https://pubmed.ncbi.nlm.nih.gov/42459945/)
**Flagged by:** diabetes-hub-monitor 2026-07-17 (cross-domain: AI/ML + Closed Loop AP + Health Equity)

## Why it surfaced
Only paper this cycle spanning three alert domains simultaneously, and it lands directly on the intersection of two Tier-1 contribution areas in the Research Doctrine: **#5 AI/ML Prediction Model Development** and **#6 Epidemiological / Health Equity Analysis**.

## What it is
A methods/framework paper (not a clinical result). It proposes a generalizable way to detect **algorithmic discrimination risk arising from subgroup imbalance in ML training data**, using pediatric type 1 diabetes as the worked case. The claim is that heterogeneous real-world data can bias model behavior against under-represented subgroups, and that this bias is detectable *before* deployment by auditing the training data composition.

## Relevance to the hub
- **Directly reusable methodology.** Our AI/ML prediction work (risk models, complication prediction) and our health-equity analyses both depend on training data whose subgroup balance we currently don't formally audit. This is a ready-made framework to adopt rather than build.
- **Fills our own gap map.** The gap analysis repeatedly flags AI/ML × Health-Equity and Closed-Loop × Health-Equity as under-researched. This paper is early evidence others are moving into that exact space — useful as both a method to cite and a marker of where the field is heading.
- **Pediatric T1D + closed-loop angle** connects to the device/AP trials we track (e.g. pediatric AID feasibility studies).

## Evidence level (per Doctrine)
**Framework / methods paper — not an empirical clinical finding.** Treat as a tool and a literature signpost, not as a validated result. No claim is asserted into the tracker on its basis. Next step if pursued: obtain full text (abstract only in corpus; no fulltext cached) and evaluate whether the framework can be applied to our existing prediction-model pipelines.

*Note: review based on title + abstract snippet in pubmed_recent_latest.json. Full text not yet retrieved.*
